Table 2.
Univariate and multivariate survival analysis within Oral Cavity N0 and N+ subgroups.
Oral Cavity NO | ||||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | |||||||
Reference | n | HR | Cl | P-Value | HR | Cl | P-Value | |
Gender | Female | 119 | 0.98 | (0.49,1.99) | 0.96 | |||
Smoker | No | 116 | 0.78 | (0.38,1.59) | 0.49 | |||
HPV Status | Positive | 119 | 1.24 | (0.3,5.17) | 0.77 | |||
Radiation | Yes | 114 | 1.94 | (0.92,4.1) | 0.082 | |||
T stage | 1,2 | 119 | 2.3 | (1.12,4.72) | 0.023 | 2.77 | (1.32,5.82) | 0.0072 |
Overall Stage | I, II | 118 | 2.48 | (1.18,5.21) | 0.017 | |||
Subtype | Non-Mesenchymal | 119 | 1.83 | (0.89,3.76) | 0.099 | 2.4 | (1.14,5.06) | 0.021 |
Age | 19-61 | 119 | 0.95 | (0.48,1.88) | 0.88 | |||
Oral Cavity N+ | ||||||||
Univariate | Multivariate | |||||||
Reference | n | HR | Cl | P-Value | HR | Cl | P-Value | |
Gender | Female | 150 | 1.06 | (0.61,1.84) | 0.83 | |||
Smoker | No | 146 | 2.09 | (1.03,4.22) | 0.041 | |||
HPV | Positive | 150 | 1 | (0.49,2.01) | 0.99 | |||
Radiation | Yes | 133 | 2.12 | (1.25,3.6) | 0.0053 | |||
T stage | 1,2 | 150 | 2.33 | (1.25,4.34) | 0.008 | |||
Overall Stage | I, II | 149 | 2.44 | (1.17,5.11) | 0.018 | |||
Subtype | Non-Mesenchymal | 150 | 1.36 | (0.84,2.21) | 0.22 | 1.3 | (0.79,2.14) | 0.3 |
Age | 19-61 | 150 | 1.3 | (0.81,2.1) | 0.28 | 1.24 | (0.76,2.01) | 0.39 |
HR, hazard ratio; CI, confidence interval.